Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix) (RECON)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
CorMatrix
ClinicalTrials.gov Identifier:
NCT02073331
First received: February 24, 2014
Last updated: May 19, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)